eosine yellowish-(ys) has been researched along with Epithelial Ovarian Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, M; Huang, X; Liu, J; Shangguan, M; Wang, T; Wu, S; Yang, Z; Zhang, C; Zhao, S | 1 |
| Boldrini, L; Fagotti, A; Giudice, MT; Inzani, F; Lenkowicz, J; Minucci, A; Nero, C; Pasciuto, T; Piermattei, A; Scambia, G; Valentini, V; Zannoni, G | 1 |
2 other study(ies) available for eosine yellowish-(ys) and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Gomisin A enhances the antitumor effect of paclitaxel by suppressing oxidative stress in ovarian cancer.
Topics: Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Complex Mixtures; Cyclin B1; Cyclin-Dependent Kinase 4; Cyclooctanes; Cysteine; Dioxoles; Eosine Yellowish-(YS); Female; Humans; Lignans; Mice; Ovarian Neoplasms; Oxidative Stress; Paclitaxel; Reactive Oxygen Species | 2022 |
Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer.
Topics: BRCA1 Protein; Carcinoma, Ovarian Epithelial; Deep Learning; Eosine Yellowish-(YS); Female; Germ-Line Mutation; Hematoxylin; Humans; Mutation; Ovarian Neoplasms | 2022 |